A detailed history of Cyndeo Wealth Partners, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Cyndeo Wealth Partners, LLC holds 16,990 shares of EYPT stock, worth $136,259. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,990
Previous 12,540 35.49%
Holding current value
$136,259
Previous $100,000 26.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$7.02 - $12.12 $31,238 - $53,934
4,450 Added 35.49%
16,990 $126,000
Q3 2024

Oct 18, 2024

BUY
$7.58 - $10.54 $95,053 - $132,171
12,540 New
12,540 $100,000

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $273M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Cyndeo Wealth Partners, LLC Portfolio

Follow Cyndeo Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyndeo Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cyndeo Wealth Partners, LLC with notifications on news.